D. Schwartz

发表

Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.

Paul Kinahan, A. Alessio, E. Ford, 2006, Medical physics.

FDG-PET prediction of head and neck squamous cell cancer outcomes.

M. Leblanc, J. Eary, K. Krohn, 2004, Archives of otolaryngology--head & neck surgery.

Postradiotherapy surveillance practice for head and neck squamous cell carcinoma—too much for too little?

K. Wallner, G. Laramore, K. Chansky, 2003, Head & neck.

Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer

David L. Schwartz, Kenneth A. Krohn, J. O'Sullivan, 2006, Clinical Cancer Research.

Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?

Radhe Mohan, Lei Dong, He Wang, 2007, International journal of radiation oncology, biology, physics.

Hypoxia and Glucose Metabolism in Malignant Tumors

F. O’Sullivan, D. Mankoff, E. Conrad, 2004, Clinical Cancer Research.

A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy.

Michalis Aristophanous, Beth M Beadle, Adam S Garden, 2015, Medical physics.

Technology Insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning

R. Weber, H. Macapinlac, S. Apisarnthanarax, 2005, Nature Clinical Practice Oncology.

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

Yoshimi Anzai, Paul Kinahan, Juergen Meyer, 2005, International journal of radiation oncology, biology, physics.

Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.

A. Garden, K. Ang, R. Weber, 2010, International journal of radiation oncology, biology, physics.

Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis.

D. Sher, L. Nedzi, D. Schwartz, 2016, Oral oncology.

The use of trimodality therapy for the treatment of operable esophageal carcinoma in the veteran population

C. Maynard, D. Schwartz, J. Dominitz, 2001, Cancer.

Tumor Hypoxia Imagingwith [F-18] Fluoromisonidazole Positron EmissionTomography in Head and Neck Cancer

J. O'Sullivan, K. Krohn, J. Grierson, 2006 .

Location as Destiny: Identifying Geospatial Disparities in Radiation Treatment Interruption by Neighborhood, Race, and Insurance.

S. Spencer, M. Pisu, D. Schwartz, 2020, International journal of radiation oncology, biology, physics.

Interruptions of Head and Neck Radiotherapy Across Insured and Indigent Patient Populations.

K. Thomas, D. Schwartz, C. Ahn, 2017, Journal of oncology practice.

The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical results.

D. Schwartz, B. Yueh, E. Vallières, 2002, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer-Reply.

D. Schwartz, S. Chun, T. Pezzi, 2018, JAMA oncology.

Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.

A. Garden, C. Fuller, V. Papadimitrakopoulou, 2017, International journal of radiation oncology, biology, physics.

Unilateral radiotherapy for the treatment of tonsil cancer.

A. Garden, K. Ang, B. Beadle, 2012, International journal of radiation oncology, biology, physics.

Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.

A. Garden, K. Ang, Douglas B. Evans, 2009, International journal of radiation oncology, biology, physics.

FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?

R. Weber, H. Macapinlac, D. Schwartz, 2008, Journal of the National Cancer Institute.

Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care.

C. Chung, D. Schwartz, 2012, Otolaryngologic clinics of North America.

The Evolving Role of Radiotherapy for Head and Neck Cancer.

D. Hayes, D. Schwartz, D. Schwartz, 2020, Hematology/oncology clinics of North America.

Predicting two‐year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma

A. Garden, B. Hobbs, B. Beadle, 2017, The Laryngoscope.

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

Ge Zhou, J. Bankson, Mei Zhao, 2011, Clinical Cancer Research.

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab

J. Welsh, D. Schwartz, L. Mayo, 2019, Front. Oncol..

Outcomes of patients with tonsillar carcinoma treated with post‐tonsillectomy radiation therapy

A. Garden, E. Sturgis, V. Papadimitrakopoulou, 2009, Head & neck.

Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison.

C. Fuller, D. Rosenthal, D. Schwartz, 2014, Oral oncology.

A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).

A. Garden, K. Ang, R. Weber, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head-and-Neck Cancer: Pilot Results From RTOG 0522

A. Garden, P. Harari, D. Schwartz, 2013 .

Co-registered FDG-PET/CT imaging for staging and IMRT treatment planning for squamous cell carcinoma of the head and neck

Paul Kinahan, E. Ford, M. Phillips, 2003 .

HIF-1–Dependent Stromal Adaptation to Ischemia Mediates In Vivo Tumor Radiation Resistance

J. Hazle, L. Bidaut, J. Bankson, 2011, Molecular Cancer Research.

The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects

J. Bankson, G. Powis, W. Bornmann, 2009, Molecular Cancer Therapeutics.

Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer

G. Hostetter, D. V. Von Hoff, J. Bankson, 2010, Molecular Cancer Therapeutics.

Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population‐based study

A. Garden, R. Weber, T. Buchholz, 2009, Head & neck.

Postoperative radiotherapy for advanced medullary thyroid cancer—Local disease control in the modern era

A. Garden, Douglas B. Evans, G. Clayman, 2008, Head & neck.

Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy

A. Garden, Douglas B. Evans, G. Clayman, 2009, Head & neck.

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

Joe Y. Chang, C. Fuller, J. Welsh, 2020, JAMA network open.

Implementing an Urban Public Health Observatory for (Near) Real-Time Surveillance for the COVID-19 Pandemic

Whitney S. Brakefield, Olufunto A. Olusanya, R. Davis, 2020, EFMI-STC.

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer

C. Fuller, J. Welsh, R. Komaki, 2018, JAMA oncology.

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

Y. Anzai, D. Schwartz, B. Yueh, 2005, Cancer.

Adaptive Radiation Therapy for Head and Neck Cancer—Can an Old Goal Evolve into a New Standard?

Lei Dong, David L. Schwartz, Lei Dong, 2010, Journal of oncology.

Initial Impact and Operational Responses to the COVID-19 Pandemic by American Radiation Oncology Practices

Benjamin D. Smith, T. DeWeese, D. Schwartz, 2020, International Journal of Radiation Oncology*Biology*Physics.

Prospective Imaging Biomarker Assessment of Mortality Risk in Patients Treated with Head and Neck Radiotherapy

A. Garden, R. Weber, S. Lippman, 2011 .

Analyzing the results of 18FMISO PET hypoxia imaging What is the best way to quantify hypoxia

M. Muzi, A. Spence, K. Krohn, 2002 .

1027 : Assessment of Positioning Accuracy of Head and Neck Patients Receiving IMRT Using On-Board Imaging and Cone Beam CT

Lei Dong, A. Garden, X. Zhu, 2006 .

Interfractional Movement of the Larynx and Oropharynx during Radiotherapy

Lei Dong, A. Garden, K. Ang, 2009 .

Candidate Dosimetric Predictors of Long-Term Swallowing Dysfunction Following Oropharyngeal IMRT

A. Garden, K. Ang, D. Rosenthal, 2014 .

Long-term radiotherapy outcomes for nasal cavity and septal cancers.

A. Garden, K. Ang, R. Weber, 2008, International journal of radiation oncology, biology, physics.

Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial.

Lei Dong, Yongbin Zhang, Adam S Garden, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes after radiotherapy for squamous cell carcinoma of the eyelid

A. Garden, K. Chao, B. Esmaeli, 2008, Cancer.

Metabolic imaging biomarkers of postradiotherapy xerostomia.

D. Schwartz, B. Cannon, L. Dong, 2012, International journal of radiation oncology, biology, physics.

Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.

A. Garden, K. Ang, S. Tucker, 2010, International journal of radiation oncology, biology, physics.

Staging of head and neck squamous cell cancer with extended-field FDG-PET.

J. Eary, Y. Anzai, K. Krohn, 2003, Archives of otolaryngology--head & neck surgery.

Imaging Epidermal Growth Factor Receptor Expression In vivo: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe

David L. Schwartz, Juri G. Gelovani, Parmeswaran Diagaradjane, 2008, Clinical Cancer Research.

Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence.

G E Laramore, G. Laramore, J. Einck, 2001, International journal of radiation oncology, biology, physics.

Peroxisome proliferator-activated receptor γ agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity

P. Wipf, G. Powis, D. Schwartz, 2009, Molecular Cancer Therapeutics.

Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment

C. Chung, B. Steinberg, D. Schwartz, 2013, Head & neck.

Radiation therapy does not impact local complication rates after free flap reconstruction for head and neck cancer.

Seungtaek L. Choi, M. Austin-Seymour, D. Schwartz, 2004, Archives of otolaryngology--head & neck surgery.

Radiotherapy for head and neck cancer.

A. Garden, D. Schwartz, D. Schwartz, 2006, Hematology/oncology clinics of North America.

Cancer Therapy : Preclinical Targeted Therapy of VEGFR 2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

Ge Zhou, J. Bankson, Mei Zhao, 2011 .

SBRT for early-stage glottic larynx cancer—Initial clinical outcomes from a phase I clinical trial

Xian-Jin Xie, R. Timmerman, L. Nedzi, 2017, PloS one.

Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.

T. Solberg, R. Timmerman, L. Nedzi, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.

T. Pandita, N. Horikoshi, R. Pandita, 2015, American journal of cancer research.

DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy

A. Garden, K. Ang, R. Weber, 2011, Clinical Cancer Research.

Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.

A. Garden, K. Ang, R. Weber, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Effect of Dental Artifacts, Contrast Media, and Experience on Interobserver Contouring Variations in Head and Neck Anatomy

He Wang, J. O'Daniel, A. Garden, 2007, American journal of clinical oncology.

Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.

A. Garden, K. Ang, C. Fuller, 2010, International journal of radiation oncology, biology, physics.

Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning

X. Gu, X. Jia, W. Lu, 2016, Journal of applied clinical medical physics.

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

Adam S Garden, K Kian Ang, A. Garden, 2009, International journal of radiation oncology, biology, physics.

Clinical Investigation : Head and Neck Cancer Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy

A. Garden, K. Ang, R. Weber, 2013 .

Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.

Lei Dong, Yongbin Zhang, Mark S Chambers, 2012, International journal of radiation oncology, biology, physics.

FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation

Yoshimi Anzai, Paul Kinahan, Eric C Ford, 2005, Head & neck.

Current Progress in Adaptive Radiation Therapy for Head and Neck Cancer

D. Schwartz, David L Schwartz, 2012, Current Oncology Reports.

Intensity-modulated radiotherapy: Is xerostomia still prevalent?

A. Garden, M. Chambers, R. Weber, 2005, Current oncology reports.

Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [F]Fluoromisonidazole and [F]Fluorodeoxyglucose Positron Emission Tomography Imaging

F. O’Sullivan, D. Mankoff, E. Conrad, 2004 .

Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by ( 18 F)Fluoromisonidazole and ( 18 F)Fluorodeoxyglucose Positron

D. Mankoff, E. Conrad, M. Muzi, 2004 .

Predictive Biomarkers and Personalized Medicine DNA Repair Biomarker Profiling of Head and Neck Cancer : Ku 80 Expression Predicts Locoregional Failure and Death following Radiotherapy

A. Garden, K. Ang, R. Weber, 2011 .

Insurance status and head and neck radiotherapy interruption disparities in the Mid‐Southern United States

S. Spencer, M. Pisu, D. Schwartz, 2020, Head & neck.

Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.

A. Garden, K. Ang, R. Weber, 2010, International Journal of Radiation Oncology, Biology, Physics.

Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.

Christopher U. Jones, A. Garden, K. Ang, 2015, International Journal of Radiation Oncology, Biology, Physics.

EGF-conjugated near-infrared quantum dots as nanoprobes for in-vivo imaging of EGFR expression

David L. Schwartz, Juri G. Gelovani, Parmeswaran Diagaradjane, 2008, SPIE BiOS.

Veterans Affairs Insurance Disparities for Metastatic Lung Cancer in the Hawaiian Islands

C. Fuller, Aileen B Chen, B. Minsky, 2020, JTO clinical and research reports.

Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients.

Radhe Mohan, Heng Li, Lei Dong, 2008, International journal of radiation oncology, biology, physics.

Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.

J. Antone, A. Riegel, D. Schwartz, 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Prospective Pharmacokinetic and Diffusion MRI Measurement of Normal Tissue Response to Head and Neck IMRT

E. Jackson, R. Bosca, D. Schwartz, 2010 .

Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer

B. Somer, M. Ballo, D. Schwartz, 2018, JAMA oncology.

The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso.

G. Laramore, E. Conrad, J. Einck, 2002, International journal of radiation oncology, biology, physics.

CLINICAL INVESTIGATION Head and Neck FDG-PET/CT IMAGING FOR PRERADIOTHERAPY STAGING OF HEAD-AND-NECK SQUAMOUS CELL CARCINOMA

Paul Kinahan, M. Leblanc, J. Eary, 2005 .